“broad-institute-of-mit-and-harvard” Archives

in
Entry Author Date Location
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Save $100 Today on “What’s Hot in Boston Biotech” on May 16 05/02/18 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
Boston Scientists Tweak CRISPR Scissors For More Precise DNA Cuts 01/06/16 Boston
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
Breaking Bottlenecks, Opening the Floodgates to Genomic Data 11/18/14 National
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders 11/25/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs 01/05/12 Boston
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics 11/07/11 Seattle
PacBio, After 7 Years and $580M, Starts Shipping New Generation DNA Sequencer 04/27/11 San Francisco
Westphal Leaving Glaxo, Cubist Settles Patent Litigation with Teva, BSX Buys S.I., & More Boston-Area Life Sciences News 04/08/11 Boston
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News 02/02/11 Boston
New Oncology R&D House H3 Biomedicine Launches in Cambridge, With Eisai Support 01/28/11 Boston
Complete Genomics Zeroes in on Tricks of Cancer Genome With Sequencing Service 12/09/10 National
NanoString Scoops Up Breast Cancer Technology, Pushes Ahead in Diagnostics 12/06/10 Seattle
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News 12/03/10 Boston
Sage Science Gets $2M 12/02/10 Boston
Amazon’s Cloud Computing Service Sees Opportunity in Genomic Data Overload 07/06/10 National
NanoString Hires Genzyme Vet as CEO to Lead Foray Into Molecular Diagnostics 06/29/10 Seattle
2010’s Innovative Dozen: The XSITE Xpo Showcase Companies 06/14/10 Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News 05/07/10 Boston
Using MIT-Harvard Technology, Ligon Discovery Speeds Up Search for New Drugs 05/04/10 Boston
Page 1 of 2 next page »